HistCite - Chimerism and Transplantation topic search

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2001
3701	3701 Sun BD, Jiang GH, Zaydan MAA, La Russa VF, Safah H, et al. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors CANCER RESEARCH. 2001 SEP 15; 61 (18): 6931-6937	0	13	1	36
3702	3702 Othman-Hassan K, Patel K, Papoutsi M, Rodriguez-Niedenfuhr M, Christ B, et al. Arterial identity of endothelial cells is controlled by local cues DEVELOPMENTAL BIOLOGY. 2001 SEP 15; 237 (2): 398-409	0	51	3	51
3703	3703 Rossi MID, Medina KL, Garrett K, Kolar G, Comp PC, et al. Relatively normal human lymphopoiesis but rapid turnover of newly formed B cells in transplanted nonobese diabetic/SCID mice JOURNAL OF IMMUNOLOGY. 2001 SEP 15; 167 (6): 3033-3042	3	26	4	77
3704	3704 Umemura A, Morita H, Li XC, Tahan S, Monaco AP, et al. Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation JOURNAL OF IMMUNOLOGY. 2001 SEP 15; 167 (6): 3043-3048	27	30	13	32
3705	3705 Foster RD, Ascher NL, McCalmont TH, Neipp M, Anthony JP, et al. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers. TRANSPLANTATION. 2001 SEP 15; 72 (5): 791-797	30	41	6	25
3706	3706 Gargollo P, Yamada K, Esnaola N, Fuchimoto Y, Newell KL, et al. Neuropathy in miniature swine after administration of the mutant diphtheria toxin-based immunotoxin, pCD3-CRM9. TRANSPLANTATION. 2001 SEP 15; 72 (5): 818-822	3	4	4	27
3707	3707 Bakonyi A, Berho M, Ruiz P, Misiakos EP, Carreno M, et al. Donor and recipient pretransplant conditioning with nonlethal radiation and antilymphocyte serum improves the graft survival in a rat small bowel transplant model TRANSPLANTATION. 2001 SEP 27; 72 (6): 983-988	2	6	12	27
3708	3708 Li S, Thanikachalam M, Pang MH, Kawaharada N, Aitouche A, et al. A clinically relevant CTLA4-Ig-based regimen induces chimerism and tolerance to heart grafts ANNALS OF THORACIC SURGERY. 2001 OCT; 72 (4): 1306-1310	3	7	12	20
3709	3709 Damiano R, Thanikachalam A clinically relevant CTLA4-Ig-based regimen induces chimerism and tolerance to heart grafts - Discussion ANNALS OF THORACIC SURGERY. 2001 OCT; 72 (4): 1310-1310	0	0	0	0
3710	3710 Kroger N, Schetelig J, Zabelina T, Kruger W, Renges H, et al. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome BONE MARROW TRANSPLANTATION. 2001 OCT; 28 (7): 643-647	7	34	6	14
#	Date / Author / Journal	LCS	GCS	LCR	CR
3711	3711 Hambach L, Eder M, Dammann E, Battmer K, Stucki A, et al. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia BONE MARROW TRANSPLANTATION. 2001 OCT; 28 (7): 705-707	9	23	2	13
3712	3712 Maury S, Belhadj K, Chami I, Kuentz M, Cordonnier C, et al. Autologous reconstitution combined with durable leukemic remission after allogeneic BMT for CML: absence of persistence of a donor-derived T cell effector population BONE MARROW TRANSPLANTATION. 2001 OCT; 28 (7): 717-720	0	1	7	10
3713	3713 Wassmann B, Klein SA, Scheuring U, Pfeifer H, Martin H, et al. Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation BONE MARROW TRANSPLANTATION. 2001 OCT; 28 (7): 721-724	2	20	4	16
3714	3714 Bleyzac N, Souillet G, Magron P, Janoly A, Martin P, et al. Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens BONE MARROW TRANSPLANTATION. 2001 OCT; 28 (8): 743-751	1	59	3	30
3715	3715 Nishio M, Nakao S, Endo T, Fujimoto K, Takashima H, et al. Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure BONE MARROW TRANSPLANTATION. 2001 OCT; 28 (8): 783-785	1	9	7	15
3716	3716 Baid S, Saidman SL, Tolkoff-Rubin N, Williams WW, Delmonico FL, et al. Managing the highly sensitized transplant recipient and B cell tolerance CURRENT OPINION IN IMMUNOLOGY. 2001 OCT; 13 (5): 577-581	3	26	3	47
3717	3717 Waldmann H Therapeutic approaches for transplantation CURRENT OPINION IN IMMUNOLOGY. 2001 OCT; 13 (5): 606-610	6	18	22	54
3718	3718 Studer M Initiation of facial motoneurone migration is dependent on rhombomeres 5 and 6 DEVELOPMENT. 2001 OCT; 128 (19): 3707-3716	1	30	5	50
3719	3719 Healy KH, Schoenwolf GC, Darnell DK Cell interactions underlying notochord induction and formation in the chick embryo DEVELOPMENTAL DYNAMICS. 2001 OCT; 222 (2): 165-177	0	2	8	88
3720	3720 Papoutsi M, Tomarev SI, Eichmann A, Prols F, Christ B, et al. Endogenous origin of the lymphatics in the avian chorioallantoic membrane DEVELOPMENTAL DYNAMICS. 2001 OCT; 222 (2): 238-251	3	44	5	51
#	Date / Author / Journal	LCS	GCS	LCR	CR
3721	3721 Soria B In-vitro differentiation of pancreatic beta-cells DIFFERENTIATION. 2001 OCT; 68 (4-5): 205-219	1	112	2	133
3722	3722 Niiya H, Kanda Y, Saito T, Ohnishi T, Kanai S, et al. Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan HAEMATOLOGICA. 2001 OCT; 86 (10): 1071-1074	10	20	10	12
3723	3723 Pulsipher MA, Woolfrey A Nonmyeloablative transplantation in children - Current status and future prospects HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. 2001 OCT; 15 (5): 809-+	2	5	20	76
3724	3724 Jain AB, Kashyap RS, Abu-Elmagd K, Fontes P, Fung JJ, et al. Use of rituximab (chimeric anti CD20 antibody) in post transplant lymphoproliferative disorder (PTLD) ater liver transplantation. HEPATOLOGY. 2001 OCT; 34 (4): 285A-285A	0	0	0	0
3725	3725 Montgomery SP, Hale DA, Hirshberg B, Harlan DM, Kirk AD Preclinical evaluation of tolerance induction protocols and islet transplantation in non-human primates IMMUNOLOGICAL REVIEWS. 2001 OCT; 183: 214-222	1	10	9	43
3726	3726 Salama AD, Remuzzi G, Harmon WE, Sayegh MH Challenges to achieving clinical transplantation tolerance JOURNAL OF CLINICAL INVESTIGATION. 2001 OCT; 108 (7): 943-948	11	72	12	50
3727	3727 Farhi DC Fluorescence DNA hybridization in the evaluation of clonal myeloid disease JOURNAL OF CLINICAL LIGAND ASSAY. 2001 FAL; 24 (3): 192-200	0	0	5	153
3728	3728 Dundas SR, Boyle S, Bellamy CO, Hawkins W, Garden OJ, et al. Dual Y-chromosome painting and immunofluorescence staining of archival human liver transplant biopsies JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 2001 OCT; 49 (10): 1321-1322	1	13	2	3
3729	3729 Nelson JL HLA relationships of pregnancy, microchimerism and autoimmune disease JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2001 OCT-NOV; 52 (1-2): 77-84	3	18	6	33
3730	3730 McSweeney P Nonmyeloablative allogeneic hematopoietic cell transplants: Any role for rheumatoid arthritis? JOURNAL OF RHEUMATOLOGY. 2001 OCT; 28: 49-54	0	3	13	28
#	Date / Author / Journal	LCS	GCS	LCR	CR
3731	3731 Starzl TE The "privileged" liver and hepatic tolerogenicity LIVER TRANSPLANTATION. 2001 OCT; 7 (10): 918-920	4	14	7	29
3732	3732 Richard E, Mendez M, Mazurier F, Morel C, Costet P, et al. Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection MOLECULAR THERAPY. 2001 OCT; 4 (4): 331-338	1	40	1	37
3733	3733 Lee WPA, Butler PEM, Randolph MA, Yaremchuk MJ Donor modification leads to prolonged survival of limb allografts PLASTIC AND RECONSTRUCTIVE SURGERY. 2001 OCT; 108 (5): 1235-1241	10	16	1	44
3734	3734 Martin L, Watier H, Vaillant L, Aractingi S Sjogren's syndrome and vitiligo in a woman with posttransfusion microchimerism AMERICAN JOURNAL OF MEDICINE. 2001 OCT 1; 111 (5): 419-421	1	2	6	10
3735	3735 Kawada H, Ogawa M Bone marrow origin of hematopoietic progenitors and stem cells in murine muscle BLOOD. 2001 OCT 1; 98 (7): 2008-2013	4	146	5	21
3736	3736 Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells CURRENT BIOLOGY. 2001 OCT 2; 11 (19): 1553-1558	2	382	0	16
3737	3737 Basker M, Alwayn IPJ, Buhler L, Harper D, Abraham S, et al. Clearance of mobilized porcine peripheral blood progenitor cells is delayed by depletion of the pragocytic reticuloendothelial system in baboons TRANSPLANTATION. 2001 OCT 15; 72 (7): 1278-1285	10	27	15	42
3738	3738 Appel JZ, Alwayn IPJ, Buhler L, DeAngelis HA, Robson SC, et al. Modulation of platelet aggregation in baboons: Implications for mixed chimerism in xenotransplantation. I. The roles of individual components of a transplantation conditioning regimen and of pig peripheral blood progenitor cells TRANSPLANTATION. 2001 OCT 15; 72 (7): 1299-1305	7	13	8	40
3739	3739 Appel JZ, Alwayn IPJ, Correa LE, Cooper DKC, Robson SC Modulation of platelet aggregation in baboons: Implications for mixed chimerism in xenotransplantation. II. The effects of cyclophosphamide on pig peripheral blood progenitor cell-induced aggregation TRANSPLANTATION. 2001 OCT 15; 72 (7): 1306-1310	3	11	5	19
3740	3740 Brouha PCR, Ildstad ST Mixed allogeneic chimerism - Past, present, and prospects for the future TRANSPLANTATION. 2001 OCT 27; 72 (8): S36-S42	9	10	38	92
#	Date / Author / Journal	LCS	GCS	LCR	CR
3741	3741 Rossini AA, Mordes JP, Greiner DL, Stoff JS Islet cell transplantation tolerance TRANSPLANTATION. 2001 OCT 27; 72 (8): S43-S46	9	30	4	24
3742	3742 Li W, Lu LN, Wang ZL, Wang LF, Fung JJ, et al. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from Flt3L-treated donors TRANSPLANTATION. 2001 OCT 27; 72 (8): 1423-1432	2	24	10	59
3743	3743 Kurtz J, Ito H, Wekerle T, Shaffer J, Sykes M Mechanisms involved in the establishment of tolerance through costimulatory blockade and BMT: Lack of requirement for CD40L-mediated signaling for tolerance or deletion of donor-reactive CD4(+) cells AMERICAN JOURNAL OF TRANSPLANTATION. 2001 NOV; 1 (4): 339-349	38	49	16	39
3744	3744 Yamane A, Karasawa M, Maeharal T, Tsukamoto N, Nojima Y X chromosome methylation-based chimerism assay for sex-mismatched hematopoietic stem cell transplantation BONE MARROW TRANSPLANTATION. 2001 NOV; 28 (10): 969-973	1	2	14	28
3745	3745 Feinstein L, Storb R Reducing transplant toxicity CURRENT OPINION IN HEMATOLOGY. 2001 NOV; 8 (6): 342-348	2	7	36	57
3746	3746 Li CL, Guo HM, Xu XL, Weinberg W, Deng CX Fibroblast growth factor receptor 2 (Fgfr2) plays an important role in eyelid and skin formation and patterning DEVELOPMENTAL DYNAMICS. 2001 NOV; 222 (3): 471-483	0	33	0	56
3747	3747 Singbartl K, Forlow SB, Ley K Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure FASEB JOURNAL. 2001 NOV; 15 (13): 2337-2344	0	59	0	50
3748	3748 Willemsen RA, Debets R, Hart E, Hoogenboom HR, Bolhuis RLH, et al. A phage display selected Fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes GENE THERAPY. 2001 NOV; 8 (21): 1601-1608	3	26	2	41
3749	3749 Bracy JL, Chase CM, Russell PS, Mauiyyedi S, Colvin RB, et al. Induction of molecular chimerism by gene therapy prevents antibody-mediated heart transplant rejection GENE THERAPY. 2001 NOV; 8 (22): 1738-1744	8	10	8	29
3750	3750 Ohashi K, Park F, Kay MA Hepatocyte transplantation: clinical and experimental application JOURNAL OF MOLECULAR MEDICINE-JMM. 2001 NOV; 79 (11): 617-630	3	79	6	115
#	Date / Author / Journal	LCS	GCS	LCR	CR
3751	3751 Kitagawa M, Aizawa S, Sado T, Yamaguchi S, Suzuki T, et al. A gene therapy model for retrovirus-induced disease with a viral env gene: expression-dependent resistance in immunosuppressed hosts LEUKEMIA. 2001 NOV; 15 (11): 1779-1784	0	5	4	42
3752	3752 Artlett CM, Miller FW, Rider LG Persistent maternally derived peripheral microchimerism is associated with the juvenile idiopathic inflammatory myopathies RHEUMATOLOGY. 2001 NOV; 40 (11): 1279-1284	5	24	5	22
3753	3753 Salama AD, Sayegh MH Achieving clinical transplant tolerance: What are the hurdles? TRANSPLANTATION PROCEEDINGS. 2001 NOV-DEC; 33 (7-8): 3038-3040	0	1	10	25
3754	3754 Haba T, Uchida K, Katayama A, Tominaga Y, Sato T, et al. Pharmacokinetics and pharmacodynamics of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in renal transplantation: A comparison between Japanese and non-Japanese patients TRANSPLANTATION PROCEEDINGS. 2001 NOV-DEC; 33 (7-8): 3174-3175	4	6	2	2
3755	3755 Monaco AP, Maki T, Hale D, Umemura A, Morita H The enigma of tolerance and chimerism: Variable role of T cells and chimerism in induction of tolerance with bone marrow TRANSPLANTATION PROCEEDINGS. 2001 NOV-DEC; 33 (7-8): 3837-3839	4	5	20	34
3756	3756 Garcia-Morales RO, Ciancio G, Mathew J, Jin Y, Rosen A, et al. Perioperative donor bone marrow infusion in cadaver kidney transplant recipients TRANSPLANTATION PROCEEDINGS. 2001 NOV-DEC; 33 (7-8): 3840-3843	0	0	11	20
3757	3757 Aristel C, Latini P, Falcinelli F, Latini RA, Aversa F The role of total body irradiation in the conditioning of patients receiving haploidentical stem cell transplantation TUMORI. 2001 NOV-DEC; 87 (6): 402-406	0	2	9	34
3758	3758 Ohdan H, Swenson KG, Kitamura H, Yang YG, Sykes M Tolerization of Gal alpha 1,3Gal-reactive B cells in pre-sensitized alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism XENOTRANSPLANTATION. 2001 NOV; 8 (4): 227-238	29	36	6	44
3759	3759 Takahashi N, Haba A, Matsuno F, Seon BK Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide CANCER RESEARCH. 2001 NOV 1; 61 (21): 7846-7854	1	77	2	55
3760	3760 Cobos I, Shimamura K, Rubenstein JLR, Martinez S, Puelles L Fate map of the avian anterior forebrain at the four-somite stage, based on the analysis of quail-chick chimeras DEVELOPMENTAL BIOLOGY. 2001 NOV 1; 239 (1): 46-67	4	83	2	63
#	Date / Author / Journal	LCS	GCS	LCR	CR
3761	3761 Williams MA, Tan JT, Adams AB, Durham MM, Shirasugi N, et al. Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance JOURNAL OF IMMUNOLOGY. 2001 NOV 1; 167 (9): 4987-4995	18	55	7	42
3762	3762 Whitney ML, Otto KG, Blau CA, Reinecke H, Murry CE Control of myoblast proliferation with a synthetic ligand. JOURNAL OF BIOLOGICAL CHEMISTRY. 2001 NOV 2; 276 (44): 41191-41196	2	23	0	32
3763	3763 Russell PS, Chase CM, Sykes M, Ito H, Shaffer J, et al. Tolerance, mixed chimerism, and chronic transplant arteriopathy JOURNAL OF IMMUNOLOGY. 2001 NOV 15; 167 (10): 5731-5740	20	55	10	51
3764	3764 Ogawa S, Nagamatsu G, Watanabe M, Watanabe S, Hayashi T, et al. Opposing effects of anti-activation-inducible lymphocyte-immunomodulatory molecule/inducible costimulator antibody on the development of acute versus chronic graft-versus-host disease JOURNAL OF IMMUNOLOGY. 2001 NOV 15; 167 (10): 5741-5748	0	44	0	57
3765	3765 Hsu LL, West C, Kean L, Archer D Predicting partial mixed chimerism in hemoglobinopathy transplant: A proposed simple math model. BLOOD. 2001 NOV 16; 98 (11): 16B-16B	0	0	0	0
3766	3766 Kang SY, Kim JH, Park JS, Kim HS, Choi JH, et al. Chimerism of hemopoietic stem cells(HSCs) and cultured mesenchymal stem cells(MSCs) following allogeneic bone marrow transplantation or cotransplantation. BLOOD. 2001 NOV 16; 98 (11): 144B-144B	0	1	0	0
3767	3767 Hayashi S, Hsieh M, Peranteau WH, Flake AW Complete donor chimerism across full allogeneic barriers achieved by in utero hematopoietic stem cell transplantation and prenatal co-transplantation of LLME treated MHC sensitized donor lymphocytes. BLOOD. 2001 NOV 16; 98 (11): 170A-170A	0	0	0	0
3768	3768 Peranteau WH, Hayashi S, Hsieh M, Shaaban AF, Flake AW Conversion of minimal allogeneic chimerism to near complete chimerism in tolerant recipients after in utero hematopoietic stem cell transplantation (IUHSCTx) by postnatal non-myeloablative total body irradiation (TBI) followed by bone marrow transplantation (BMT). BLOOD. 2001 NOV 16; 98 (11): 170A-170A	0	0	0	0
3769	3769 Hayashi S, Peranteau WH, Abdulmalik O, Chen QK, Horiuchi K, et al. High level of allogeneic engraftment after postnatal boosting with nonmyeloablative regimen can ameliorate diseases in mixed chimeric hemoglobinopathy mice model after in utero hematopoietic stem cell transplantation. BLOOD. 2001 NOV 16; 98 (11): 170A-171A	0	0	0	0
3770	3770 Hayashi S, Abdulmalik O, Peranteau WH, Chen QK, Asakura T, et al. Mixed chimerism following in utero hematopoietic stem cell transplantation in murine models of hemoglobinopathy: The selective advantage for donor erythropoiesis is enhanced by fetal liver donor source and shortened red cell half-life. BLOOD. 2001 NOV 16; 98 (11): 171A-171A	0	0	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
3771	3771 Kean L, Durham M, Adams A, Hsu LL, Pearson T, et al. Progressive correction of murine Sickle cell disease with increasing levels of red cell chimerism after allogeneic bone marrow transplantation. BLOOD. 2001 NOV 16; 98 (11): 172A-172A	0	0	0	0
3772	3772 Bock SH, Pihusch M, Heller T, Schoch C, Haferlach T, et al. Chimerism of peripheral blood dendritic cells in patients after allogeneic hematopoietic cell transplantation. BLOOD. 2001 NOV 16; 98 (11): 188A-188A	1	1	0	0
3773	3773 Theil K, Warshawsky I, Tubbs R, Shadrach B, Serafino S, et al. Chimerism analysis in peripheral blood buffy coat and T-cell fractions after non-myeloablative allogeneic peripheral blood stem cell transplant (PBSCT). BLOOD. 2001 NOV 16; 98 (11): 188A-189A	0	0	0	0
3774	3774 Theil K, Warshawsky I, Tubbs R, Shadrach B, Serafino S, et al. Dynamics of T-cell (CD3+) mixed chimerism after non-myeloablative allogeneic peripheral blood stem cell transplant (PBSCT). BLOOD. 2001 NOV 16; 98 (11): 189A-189A	1	1	0	0
3775	3775 Fernandez-Aviles F, Urbano-Ispizua A, Aymerich M, Colomer D, Rovira M, et al. Serial quantification of mixed chimerism of T-cells and myeloid cells predicts graft rejection and relapse, respectively, after allogeneic CD34(+) selected peripheral blood cell transplants (ALLO-PBT/CD34(+)). BLOOD. 2001 NOV 16; 98 (11): 190A-190A	0	0	0	0
3776	3776 Winkler J, Biller A, Rosler W, Schaefer-Eckart K, Wandt H, et al. Chimerism of B lymphoid precursor cells after allogeneic transplantation: Comparison bone marrow to G-CSF mobilized stem cells. BLOOD. 2001 NOV 16; 98 (11): 190A-190A	0	0	0	0
3777	3777 Chandy M, Srivastava A, Poonkuzhali B, Shaji RV, Mathews V, et al. Comparison of different genetic markers in the evaluation of chimerism after allogeneic bone marrow transplantation in the Indian population. BLOOD. 2001 NOV 16; 98 (11): 191A-191A	0	0	0	0
3778	3778 Arranz E, Cannata J, Granda A, Sanz F, Alegre A, et al. Detection of mixed chimerism and minimal residual disease (MRD) after sex-mismatch hematopoietic transplantation in chronic myeloid leukemia (CML) by fluorescence in situ hybridization (FISH). BLOOD. 2001 NOV 16; 98 (11): 255B-255B	0	0	0	0
3779	3779 Down JD, Johnson KW, Morgan P, Awwad M, White-Scharf ME Role of donor T cells on induction of MHC-mismatched donor-type chimerism following non-myeloablative transplant conditioning. BLOOD. 2001 NOV 16; 98 (11): 315B-315B	0	0	0	0
3780	3780 Keil F, Prinz E, Kalhs P, Mannhalter C, Worel N, et al. Kinetic of lymphohematopoietic chimerism in dose reduced allogeneic stem cell transplantation. BLOOD. 2001 NOV 16; 98 (11): 317B-318B	0	0	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
3781	3781 McDermott DF, Vasir D, Joyce R, Levine J, Uhl L, et al. Dendritic cell chimerism and immune reconstitution following non-myeloablative transplantation. BLOOD. 2001 NOV 16; 98 (11): 319B-319B	0	0	0	0
3782	3782 Peranteau WH, Hayashi S, Ashizuka S, Hsieh M, Flake AW Moderate enhancement of allogeneic chimerism following a postnatal cyclophosphamide (CP) based transplant regimen in recipients made tolerant by in utero hematopoietic stem cell transplantation (IUHSCTx). BLOOD. 2001 NOV 16; 98 (11): 319B-319B	0	0	0	0
3783	3783 Sefrioui H, Donahue J, Srivastava AS, Lee TH, Busch MP, et al. Immunity without microchimerism after in utero transplantation of hematopoietic stem cells. BLOOD. 2001 NOV 16; 98 (11): 320B-320B	0	0	0	0
3784	3784 Chan G, Gorgun G, Miller K, Roberts T, Sprague K, et al. Host dendritic cell chimerism after allogeneic bone marrow transplant may be predictive of acute and chronic graft versus host disease. BLOOD. 2001 NOV 16; 98 (11): 324B-324B	0	0	0	0
3785	3785 Buno I, Anta B, Moreno-Lopez E, Balsalobre P, Serrano D, et al. Lineage specific chimerism quantification allows the early diagnosis of graft rejection after allogeneic stem cell transplant and successful treatment with donor leukocyte infusions. BLOOD. 2001 NOV 16; 98 (11): 343B-343B	0	0	0	0
3786	3786 Buno I, Anta B, Moreno-Lopez E, Balsalobre P, Balas A, et al. Lineage specific chimerism quantification after T-cell depleted peripheral blood stem cell transplantation. BLOOD. 2001 NOV 16; 98 (11): 343B-344B	0	0	0	0
3787	3787 Galimberti S, Morabito F, Benedetti E, Fazzi R, Papineschi F, et al. Molecular monitoring of chimerism in non myeloablative stem cell transplantation. BLOOD. 2001 NOV 16; 98 (11): 347B-347B	0	0	0	0
3788	3788 Kaplinsky C, Hardan I, Toren A, Reichart M, Daniely M, et al. Minimal residual disease and chimerism detection after bone-marrow transplantation using an automatic cell scanning system. BLOOD. 2001 NOV 16; 98 (11): 348B-348B	1	1	0	0
3789	3789 Shimony A, Trakhtenbort L, Malka R, Michal D, Yulia Z, et al. Chimerism testing and detection of minimal residual disease in a patient with Ph plus acute lymphoblastic leukemia after bone marrow transplantation using multiparametric cell scanning system. BLOOD. 2001 NOV 16; 98 (11): 352B-352B	1	1	0	0
3790	3790 Turkiewicz D, Gorczynska E, Toporski J, Rybka B, Kalwak K, et al. Serial and quantitative monitoring of hematopoietic chimerism in children with malignant diseases after allogeneic hematopoietic progenitor cell transplantation (alloHPCT). BLOOD. 2001 NOV 16; 98 (11): 352B-352B	0	0	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
3791	3791 Bolwell BJ, Pohlman B, Sobecks R, Andresen S, Rybicki L, et al. Hypogammaglobulinemia following non-myeloablative allogeneic stem cell transplant correlates with chimerism. BLOOD. 2001 NOV 16; 98 (11): 353B-353B	0	0	0	0
3792	3792 Buergi A, Passweg JR, Gregor M, Tichelli A, Gratwohl A Syngenic stem cell transplantation to reverse donor type chimerism and chronic GvHD following an allogeneic transplant. BLOOD. 2001 NOV 16; 98 (11): 364B-364B	0	0	0	0
3793	3793 Chiorean EG, DeFor TE, Blazar BR, Weisdorf DJ, McGlave PB, et al. Effect of donor chimerism on the GVHD risk and response to DLI for relapsed hematological malignancies after allogeneic transplantation. BLOOD. 2001 NOV 16; 98 (11): 364B-364B	0	0	0	0
3794	3794 Kim YM, Mapara MY, Sykes M Predominant role of CD8(+) T cells in the lymphohematopoietic graft-versus-host reaction mediated by donor lymphocyte infusion (DLI) in murine mixed chimeras. BLOOD. 2001 NOV 16; 98 (11): 381A-381A	0	0	0	0
3795	3795 de Lima M, Komanduri K, StJohn L, Wieder E, Lee M, et al. Using two mismatched unrelated donor cord blood units for transplantation: Analysis of chimerism and immune reconstitution. BLOOD. 2001 NOV 16; 98 (11): 382B-382B	0	0	0	0
3796	3796 Hayashi S, Peranteau WH, Shaaban AF, Flake AW Complete allogeneic hematopoietic chimerism without cytoreductive conditioning or immunosuppression: A combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. BLOOD. 2001 NOV 16; 98 (11): 383A-383A	0	0	0	0
3797	3797 Hou JW, Fowler DH, Wilson W, Gress R, Kasten-Sportes C, et al. Potent graft-versus-lymphoma effect after non-myeloablative stem cell transplant in refractory non-Hodgkin's lymphoma: Role of rapid complete donor chimerism. BLOOD. 2001 NOV 16; 98 (11): 404A-404A	1	2	0	0
3798	3798 Scheffold C, Kroeger MJ, Silling G, Leo R, Zuehlsdorf M, et al. Decreasing donor cell chimerism (DCC) in marrow CD34+ cells indicates relapse in acute myeloid leukemia (AML) after allogeneic stem cell transplantation. BLOOD. 2001 NOV 16; 98 (11): 405A-405A	0	0	0	0
3799	3799 Dey BR, McAfee SL, Colby C, Sackstein R, Saidman S, et al. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-vs-host disease (GvHD) and anti-tumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic stem cell transplantation (SCT). BLOOD. 2001 NOV 16; 98 (11): 417A-417A	0	0	0	0
3800	3800 Dey BR, McAfee SL, Sackstein R, Colby C, Sahai S, et al. Achievement of sustained remissions despite loss of donor chimerism (DC) in patients with chemotherapy-refractory non-Hodgkin's lymphoma (NHL) treated with nonmyeloablative conditioning and allogeneic stem cell transplantation (SCT). BLOOD. 2001 NOV 16; 98 (11): 418A-418A	0	0	0	0

Date / Author / Journal

LCS

GCS

LCR

2001

3701

3701 Sun BD, Jiang GH, Zaydan MAA, La Russa VF, Safah H, et al.

ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors

CANCER RESEARCH. 2001 SEP 15; 61 (18): 6931-6937

3702

3702 Othman-Hassan K, Patel K, Papoutsi M, Rodriguez-Niedenfuhr M, Christ B, et al.

Arterial identity of endothelial cells is controlled by local cues

DEVELOPMENTAL BIOLOGY. 2001 SEP 15; 237 (2): 398-409

3703

3703 Rossi MID, Medina KL, Garrett K, Kolar G, Comp PC, et al.

Relatively normal human lymphopoiesis but rapid turnover of newly formed B cells in transplanted nonobese diabetic/SCID mice

JOURNAL OF IMMUNOLOGY. 2001 SEP 15; 167 (6): 3033-3042

3704

3704 Umemura A, Morita H, Li XC, Tahan S, Monaco AP, et al.

Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation

JOURNAL OF IMMUNOLOGY. 2001 SEP 15; 167 (6): 3043-3048

3705

3705 Foster RD, Ascher NL, McCalmont TH, Neipp M, Anthony JP, et al.

Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.

TRANSPLANTATION. 2001 SEP 15; 72 (5): 791-797

3706

3706 Gargollo P, Yamada K, Esnaola N, Fuchimoto Y, Newell KL, et al.

Neuropathy in miniature swine after administration of the mutant diphtheria toxin-based immunotoxin, pCD3-CRM9.

TRANSPLANTATION. 2001 SEP 15; 72 (5): 818-822

3707

3707 Bakonyi A, Berho M, Ruiz P, Misiakos EP, Carreno M, et al.

Donor and recipient pretransplant conditioning with nonlethal radiation and antilymphocyte serum improves the graft survival in a rat small bowel transplant model

TRANSPLANTATION. 2001 SEP 27; 72 (6): 983-988

3708

3708 Li S, Thanikachalam M, Pang MH, Kawaharada N, Aitouche A, et al.

A clinically relevant CTLA4-Ig-based regimen induces chimerism and tolerance to heart grafts

ANNALS OF THORACIC SURGERY. 2001 OCT; 72 (4): 1306-1310

3709

3709 Damiano R, Thanikachalam

A clinically relevant CTLA4-Ig-based regimen induces chimerism and tolerance to heart grafts - Discussion

ANNALS OF THORACIC SURGERY. 2001 OCT; 72 (4): 1310-1310

3710

3710 Kroger N, Schetelig J, Zabelina T, Kruger W, Renges H, et al.

A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome

BONE MARROW TRANSPLANTATION. 2001 OCT; 28 (7): 643-647

Date / Author / Journal

LCS

GCS

LCR

3711

3711 Hambach L, Eder M, Dammann E, Battmer K, Stucki A, et al.

Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia

BONE MARROW TRANSPLANTATION. 2001 OCT; 28 (7): 705-707

3712

3712 Maury S, Belhadj K, Chami I, Kuentz M, Cordonnier C, et al.

Autologous reconstitution combined with durable leukemic remission after allogeneic BMT for CML: absence of persistence of a donor-derived T cell effector population

BONE MARROW TRANSPLANTATION. 2001 OCT; 28 (7): 717-720

3713

3713 Wassmann B, Klein SA, Scheuring U, Pfeifer H, Martin H, et al.

Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation

BONE MARROW TRANSPLANTATION. 2001 OCT; 28 (7): 721-724

3714

3714 Bleyzac N, Souillet G, Magron P, Janoly A, Martin P, et al.

Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens

BONE MARROW TRANSPLANTATION. 2001 OCT; 28 (8): 743-751

3715

3715 Nishio M, Nakao S, Endo T, Fujimoto K, Takashima H, et al.

Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure

BONE MARROW TRANSPLANTATION. 2001 OCT; 28 (8): 783-785

3716

3716 Baid S, Saidman SL, Tolkoff-Rubin N, Williams WW, Delmonico FL, et al.

Managing the highly sensitized transplant recipient and B cell tolerance

CURRENT OPINION IN IMMUNOLOGY. 2001 OCT; 13 (5): 577-581

3717

3717 Waldmann H

Therapeutic approaches for transplantation

CURRENT OPINION IN IMMUNOLOGY. 2001 OCT; 13 (5): 606-610

3718

3718 Studer M

Initiation of facial motoneurone migration is dependent on rhombomeres 5 and 6

DEVELOPMENT. 2001 OCT; 128 (19): 3707-3716

3719

3719 Healy KH, Schoenwolf GC, Darnell DK

Cell interactions underlying notochord induction and formation in the chick embryo

DEVELOPMENTAL DYNAMICS. 2001 OCT; 222 (2): 165-177

3720

3720 Papoutsi M, Tomarev SI, Eichmann A, Prols F, Christ B, et al.

Endogenous origin of the lymphatics in the avian chorioallantoic membrane

DEVELOPMENTAL DYNAMICS. 2001 OCT; 222 (2): 238-251

Date / Author / Journal

3721

In-vitro differentiation of pancreatic beta-cells

DIFFERENTIATION. 2001 OCT; 68 (4-5): 205-219

112

133

3722

3722 Niiya H, Kanda Y, Saito T, Ohnishi T, Kanai S, et al.

Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan

HAEMATOLOGICA. 2001 OCT; 86 (10): 1071-1074

3723

3723 Pulsipher MA, Woolfrey A

Nonmyeloablative transplantation in children - Current status and future prospects

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. 2001 OCT; 15 (5): 809-+

3724

3724 Jain AB, Kashyap RS, Abu-Elmagd K, Fontes P, Fung JJ, et al.

Use of rituximab (chimeric anti CD20 antibody) in post transplant lymphoproliferative disorder (PTLD) ater liver transplantation.

HEPATOLOGY. 2001 OCT; 34 (4): 285A-285A

3725

3725 Montgomery SP, Hale DA, Hirshberg B, Harlan DM, Kirk AD

Preclinical evaluation of tolerance induction protocols and islet transplantation in non-human primates

IMMUNOLOGICAL REVIEWS. 2001 OCT; 183: 214-222

3726

3726 Salama AD, Remuzzi G, Harmon WE, Sayegh MH

Challenges to achieving clinical transplantation tolerance

JOURNAL OF CLINICAL INVESTIGATION. 2001 OCT; 108 (7): 943-948

3727

3727 Farhi DC

Fluorescence DNA hybridization in the evaluation of clonal myeloid disease

JOURNAL OF CLINICAL LIGAND ASSAY. 2001 FAL; 24 (3): 192-200

153

3728

3728 Dundas SR, Boyle S, Bellamy CO, Hawkins W, Garden OJ, et al.

Dual Y-chromosome painting and immunofluorescence staining of archival human liver transplant biopsies

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 2001 OCT; 49 (10): 1321-1322

3729

3729 Nelson JL

HLA relationships of pregnancy, microchimerism and autoimmune disease

JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2001 OCT-NOV; 52 (1-2): 77-84

3730

3730 McSweeney P

Nonmyeloablative allogeneic hematopoietic cell transplants: Any role for rheumatoid arthritis?

JOURNAL OF RHEUMATOLOGY. 2001 OCT; 28: 49-54

Date / Author / Journal

3731

The "privileged" liver and hepatic tolerogenicity

LIVER TRANSPLANTATION. 2001 OCT; 7 (10): 918-920

3732

3732 Richard E, Mendez M, Mazurier F, Morel C, Costet P, et al.

Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection

MOLECULAR THERAPY. 2001 OCT; 4 (4): 331-338

3733

3733 Lee WPA, Butler PEM, Randolph MA, Yaremchuk MJ

Donor modification leads to prolonged survival of limb allografts

PLASTIC AND RECONSTRUCTIVE SURGERY. 2001 OCT; 108 (5): 1235-1241

3734

3734 Martin L, Watier H, Vaillant L, Aractingi S

Sjogren's syndrome and vitiligo in a woman with posttransfusion microchimerism

AMERICAN JOURNAL OF MEDICINE. 2001 OCT 1; 111 (5): 419-421

3735

3735 Kawada H, Ogawa M

Bone marrow origin of hematopoietic progenitors and stem cells in murine muscle

BLOOD. 2001 OCT 1; 98 (7): 2008-2013

146

3736

3736 Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T

Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells

CURRENT BIOLOGY. 2001 OCT 2; 11 (19): 1553-1558

382

3737

3737 Basker M, Alwayn IPJ, Buhler L, Harper D, Abraham S, et al.

Clearance of mobilized porcine peripheral blood progenitor cells is delayed by depletion of the pragocytic reticuloendothelial system in baboons

TRANSPLANTATION. 2001 OCT 15; 72 (7): 1278-1285

3738

3738 Appel JZ, Alwayn IPJ, Buhler L, DeAngelis HA, Robson SC, et al.

Modulation of platelet aggregation in baboons: Implications for mixed chimerism in xenotransplantation. I. The roles of individual components of a transplantation conditioning regimen and of pig peripheral blood progenitor cells

TRANSPLANTATION. 2001 OCT 15; 72 (7): 1299-1305

3739

3739 Appel JZ, Alwayn IPJ, Correa LE, Cooper DKC, Robson SC

Modulation of platelet aggregation in baboons: Implications for mixed chimerism in xenotransplantation. II. The effects of cyclophosphamide on pig peripheral blood progenitor cell-induced aggregation

TRANSPLANTATION. 2001 OCT 15; 72 (7): 1306-1310

3740

3740 Brouha PCR, Ildstad ST

Mixed allogeneic chimerism - Past, present, and prospects for the future

TRANSPLANTATION. 2001 OCT 27; 72 (8): S36-S42

Date / Author / Journal

LCS

GCS

LCR

3741

3741 Rossini AA, Mordes JP, Greiner DL, Stoff JS

Islet cell transplantation tolerance

TRANSPLANTATION. 2001 OCT 27; 72 (8): S43-S46

3742

3742 Li W, Lu LN, Wang ZL, Wang LF, Fung JJ, et al.

Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from Flt3L-treated donors

TRANSPLANTATION. 2001 OCT 27; 72 (8): 1423-1432

3743

3743 Kurtz J, Ito H, Wekerle T, Shaffer J, Sykes M

Mechanisms involved in the establishment of tolerance through costimulatory blockade and BMT: Lack of requirement for CD40L-mediated signaling for tolerance or deletion of donor-reactive CD4(+) cells

AMERICAN JOURNAL OF TRANSPLANTATION. 2001 NOV; 1 (4): 339-349

3744

3744 Yamane A, Karasawa M, Maeharal T, Tsukamoto N, Nojima Y

X chromosome methylation-based chimerism assay for sex-mismatched hematopoietic stem cell transplantation

BONE MARROW TRANSPLANTATION. 2001 NOV; 28 (10): 969-973

3745

3745 Feinstein L, Storb R

Reducing transplant toxicity

CURRENT OPINION IN HEMATOLOGY. 2001 NOV; 8 (6): 342-348

3746

3746 Li CL, Guo HM, Xu XL, Weinberg W, Deng CX

Fibroblast growth factor receptor 2 (Fgfr2) plays an important role in eyelid and skin formation and patterning

DEVELOPMENTAL DYNAMICS. 2001 NOV; 222 (3): 471-483

3747

3747 Singbartl K, Forlow SB, Ley K

Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure

FASEB JOURNAL. 2001 NOV; 15 (13): 2337-2344

3748

3748 Willemsen RA, Debets R, Hart E, Hoogenboom HR, Bolhuis RLH, et al.

A phage display selected Fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes

GENE THERAPY. 2001 NOV; 8 (21): 1601-1608

3749

3749 Bracy JL, Chase CM, Russell PS, Mauiyyedi S, Colvin RB, et al.

Induction of molecular chimerism by gene therapy prevents antibody-mediated heart transplant rejection

GENE THERAPY. 2001 NOV; 8 (22): 1738-1744

3750

3750 Ohashi K, Park F, Kay MA

Hepatocyte transplantation: clinical and experimental application

JOURNAL OF MOLECULAR MEDICINE-JMM. 2001 NOV; 79 (11): 617-630

115

Date / Author / Journal

LCS

GCS

LCR

3751

3751 Kitagawa M, Aizawa S, Sado T, Yamaguchi S, Suzuki T, et al.

A gene therapy model for retrovirus-induced disease with a viral env gene: expression-dependent resistance in immunosuppressed hosts

LEUKEMIA. 2001 NOV; 15 (11): 1779-1784

3752

3752 Artlett CM, Miller FW, Rider LG

Persistent maternally derived peripheral microchimerism is associated with the juvenile idiopathic inflammatory myopathies

RHEUMATOLOGY. 2001 NOV; 40 (11): 1279-1284

3753

3753 Salama AD, Sayegh MH

Achieving clinical transplant tolerance: What are the hurdles?

TRANSPLANTATION PROCEEDINGS. 2001 NOV-DEC; 33 (7-8): 3038-3040

3754

3754 Haba T, Uchida K, Katayama A, Tominaga Y, Sato T, et al.

Pharmacokinetics and pharmacodynamics of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in renal transplantation: A comparison between Japanese and non-Japanese patients

TRANSPLANTATION PROCEEDINGS. 2001 NOV-DEC; 33 (7-8): 3174-3175

3755

3755 Monaco AP, Maki T, Hale D, Umemura A, Morita H

The enigma of tolerance and chimerism: Variable role of T cells and chimerism in induction of tolerance with bone marrow

TRANSPLANTATION PROCEEDINGS. 2001 NOV-DEC; 33 (7-8): 3837-3839

3756

3756 Garcia-Morales RO, Ciancio G, Mathew J, Jin Y, Rosen A, et al.

Perioperative donor bone marrow infusion in cadaver kidney transplant recipients

TRANSPLANTATION PROCEEDINGS. 2001 NOV-DEC; 33 (7-8): 3840-3843

3757

3757 Aristel C, Latini P, Falcinelli F, Latini RA, Aversa F

The role of total body irradiation in the conditioning of patients receiving haploidentical stem cell transplantation

TUMORI. 2001 NOV-DEC; 87 (6): 402-406

3758

3758 Ohdan H, Swenson KG, Kitamura H, Yang YG, Sykes M

Tolerization of Gal alpha 1,3Gal-reactive B cells in pre-sensitized alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism

XENOTRANSPLANTATION. 2001 NOV; 8 (4): 227-238

3759

3759 Takahashi N, Haba A, Matsuno F, Seon BK

Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide

CANCER RESEARCH. 2001 NOV 1; 61 (21): 7846-7854

3760

3760 Cobos I, Shimamura K, Rubenstein JLR, Martinez S, Puelles L

Fate map of the avian anterior forebrain at the four-somite stage, based on the analysis of quail-chick chimeras

DEVELOPMENTAL BIOLOGY. 2001 NOV 1; 239 (1): 46-67

Date / Author / Journal

LCS

GCS

LCR

3761

3761 Williams MA, Tan JT, Adams AB, Durham MM, Shirasugi N, et al.

Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance

JOURNAL OF IMMUNOLOGY. 2001 NOV 1; 167 (9): 4987-4995

3762

3762 Whitney ML, Otto KG, Blau CA, Reinecke H, Murry CE

Control of myoblast proliferation with a synthetic ligand.

JOURNAL OF BIOLOGICAL CHEMISTRY. 2001 NOV 2; 276 (44): 41191-41196

3763

3763 Russell PS, Chase CM, Sykes M, Ito H, Shaffer J, et al.

Tolerance, mixed chimerism, and chronic transplant arteriopathy

JOURNAL OF IMMUNOLOGY. 2001 NOV 15; 167 (10): 5731-5740

3764

3764 Ogawa S, Nagamatsu G, Watanabe M, Watanabe S, Hayashi T, et al.

Opposing effects of anti-activation-inducible lymphocyte-immunomodulatory molecule/inducible costimulator antibody on the development of acute versus chronic graft-versus-host disease

JOURNAL OF IMMUNOLOGY. 2001 NOV 15; 167 (10): 5741-5748

3765

3765 Hsu LL, West C, Kean L, Archer D

Predicting partial mixed chimerism in hemoglobinopathy transplant: A proposed simple math model.

BLOOD. 2001 NOV 16; 98 (11): 16B-16B

3766

3766 Kang SY, Kim JH, Park JS, Kim HS, Choi JH, et al.

Chimerism of hemopoietic stem cells(HSCs) and cultured mesenchymal stem cells(MSCs) following allogeneic bone marrow transplantation or cotransplantation.

BLOOD. 2001 NOV 16; 98 (11): 144B-144B

3767

3767 Hayashi S, Hsieh M, Peranteau WH, Flake AW

Complete donor chimerism across full allogeneic barriers achieved by in utero hematopoietic stem cell transplantation and prenatal co-transplantation of LLME treated MHC sensitized donor lymphocytes.

BLOOD. 2001 NOV 16; 98 (11): 170A-170A

3768

3768 Peranteau WH, Hayashi S, Hsieh M, Shaaban AF, Flake AW

Conversion of minimal allogeneic chimerism to near complete chimerism in tolerant recipients after in utero hematopoietic stem cell transplantation (IUHSCTx) by postnatal non-myeloablative total body irradiation (TBI) followed by bone marrow transplantation (BMT).

BLOOD. 2001 NOV 16; 98 (11): 170A-170A

3769

3769 Hayashi S, Peranteau WH, Abdulmalik O, Chen QK, Horiuchi K, et al.

High level of allogeneic engraftment after postnatal boosting with nonmyeloablative regimen can ameliorate diseases in mixed chimeric hemoglobinopathy mice model after in utero hematopoietic stem cell transplantation.

BLOOD. 2001 NOV 16; 98 (11): 170A-171A

3770

3770 Hayashi S, Abdulmalik O, Peranteau WH, Chen QK, Asakura T, et al.

Mixed chimerism following in utero hematopoietic stem cell transplantation in murine models of hemoglobinopathy: The selective advantage for donor erythropoiesis is enhanced by fetal liver donor source and shortened red cell half-life.

BLOOD. 2001 NOV 16; 98 (11): 171A-171A

Date / Author / Journal

LCS

GCS

LCR

3771

3771 Kean L, Durham M, Adams A, Hsu LL, Pearson T, et al.

Progressive correction of murine Sickle cell disease with increasing levels of red cell chimerism after allogeneic bone marrow transplantation.

BLOOD. 2001 NOV 16; 98 (11): 172A-172A

3772

3772 Bock SH, Pihusch M, Heller T, Schoch C, Haferlach T, et al.

Chimerism of peripheral blood dendritic cells in patients after allogeneic hematopoietic cell transplantation.

BLOOD. 2001 NOV 16; 98 (11): 188A-188A

3773

3773 Theil K, Warshawsky I, Tubbs R, Shadrach B, Serafino S, et al.

Chimerism analysis in peripheral blood buffy coat and T-cell fractions after non-myeloablative allogeneic peripheral blood stem cell transplant (PBSCT).

BLOOD. 2001 NOV 16; 98 (11): 188A-189A

3774

3774 Theil K, Warshawsky I, Tubbs R, Shadrach B, Serafino S, et al.

Dynamics of T-cell (CD3+) mixed chimerism after non-myeloablative allogeneic peripheral blood stem cell transplant (PBSCT).

BLOOD. 2001 NOV 16; 98 (11): 189A-189A

3775

3775 Fernandez-Aviles F, Urbano-Ispizua A, Aymerich M, Colomer D, Rovira M, et al.

Serial quantification of mixed chimerism of T-cells and myeloid cells predicts graft rejection and relapse, respectively, after allogeneic CD34(+) selected peripheral blood cell transplants (ALLO-PBT/CD34(+)).

BLOOD. 2001 NOV 16; 98 (11): 190A-190A

3776

3776 Winkler J, Biller A, Rosler W, Schaefer-Eckart K, Wandt H, et al.

Chimerism of B lymphoid precursor cells after allogeneic transplantation: Comparison bone marrow to G-CSF mobilized stem cells.

BLOOD. 2001 NOV 16; 98 (11): 190A-190A

3777

3777 Chandy M, Srivastava A, Poonkuzhali B, Shaji RV, Mathews V, et al.

Comparison of different genetic markers in the evaluation of chimerism after allogeneic bone marrow transplantation in the Indian population.

BLOOD. 2001 NOV 16; 98 (11): 191A-191A

3778

3778 Arranz E, Cannata J, Granda A, Sanz F, Alegre A, et al.

Detection of mixed chimerism and minimal residual disease (MRD) after sex-mismatch hematopoietic transplantation in chronic myeloid leukemia (CML) by fluorescence in situ hybridization (FISH).

BLOOD. 2001 NOV 16; 98 (11): 255B-255B

3779

3779 Down JD, Johnson KW, Morgan P, Awwad M, White-Scharf ME

Role of donor T cells on induction of MHC-mismatched donor-type chimerism following non-myeloablative transplant conditioning.

BLOOD. 2001 NOV 16; 98 (11): 315B-315B

3780

3780 Keil F, Prinz E, Kalhs P, Mannhalter C, Worel N, et al.

Kinetic of lymphohematopoietic chimerism in dose reduced allogeneic stem cell transplantation.

BLOOD. 2001 NOV 16; 98 (11): 317B-318B

Date / Author / Journal

LCS

GCS

LCR

3781

3781 McDermott DF, Vasir D, Joyce R, Levine J, Uhl L, et al.

Dendritic cell chimerism and immune reconstitution following non-myeloablative transplantation.

BLOOD. 2001 NOV 16; 98 (11): 319B-319B

3782

3782 Peranteau WH, Hayashi S, Ashizuka S, Hsieh M, Flake AW

Moderate enhancement of allogeneic chimerism following a postnatal cyclophosphamide (CP) based transplant regimen in recipients made tolerant by in utero hematopoietic stem cell transplantation (IUHSCTx).

BLOOD. 2001 NOV 16; 98 (11): 319B-319B

3783

3783 Sefrioui H, Donahue J, Srivastava AS, Lee TH, Busch MP, et al.

Immunity without microchimerism after in utero transplantation of hematopoietic stem cells.

BLOOD. 2001 NOV 16; 98 (11): 320B-320B

3784

3784 Chan G, Gorgun G, Miller K, Roberts T, Sprague K, et al.

Host dendritic cell chimerism after allogeneic bone marrow transplant may be predictive of acute and chronic graft versus host disease.

BLOOD. 2001 NOV 16; 98 (11): 324B-324B

3785

3785 Buno I, Anta B, Moreno-Lopez E, Balsalobre P, Serrano D, et al.

Lineage specific chimerism quantification allows the early diagnosis of graft rejection after allogeneic stem cell transplant and successful treatment with donor leukocyte infusions.

BLOOD. 2001 NOV 16; 98 (11): 343B-343B

3786

3786 Buno I, Anta B, Moreno-Lopez E, Balsalobre P, Balas A, et al.

Lineage specific chimerism quantification after T-cell depleted peripheral blood stem cell transplantation.

BLOOD. 2001 NOV 16; 98 (11): 343B-344B

3787

3787 Galimberti S, Morabito F, Benedetti E, Fazzi R, Papineschi F, et al.

Molecular monitoring of chimerism in non myeloablative stem cell transplantation.

BLOOD. 2001 NOV 16; 98 (11): 347B-347B

3788

3788 Kaplinsky C, Hardan I, Toren A, Reichart M, Daniely M, et al.

Minimal residual disease and chimerism detection after bone-marrow transplantation using an automatic cell scanning system.

BLOOD. 2001 NOV 16; 98 (11): 348B-348B

3789

3789 Shimony A, Trakhtenbort L, Malka R, Michal D, Yulia Z, et al.

Chimerism testing and detection of minimal residual disease in a patient with Ph plus acute lymphoblastic leukemia after bone marrow transplantation using multiparametric cell scanning system.

BLOOD. 2001 NOV 16; 98 (11): 352B-352B

3790

3790 Turkiewicz D, Gorczynska E, Toporski J, Rybka B, Kalwak K, et al.

Serial and quantitative monitoring of hematopoietic chimerism in children with malignant diseases after allogeneic hematopoietic progenitor cell transplantation (alloHPCT).

BLOOD. 2001 NOV 16; 98 (11): 352B-352B

Date / Author / Journal

LCS

GCS

LCR

3791

3791 Bolwell BJ, Pohlman B, Sobecks R, Andresen S, Rybicki L, et al.

Hypogammaglobulinemia following non-myeloablative allogeneic stem cell transplant correlates with chimerism.

BLOOD. 2001 NOV 16; 98 (11): 353B-353B

3792

3792 Buergi A, Passweg JR, Gregor M, Tichelli A, Gratwohl A

Syngenic stem cell transplantation to reverse donor type chimerism and chronic GvHD following an allogeneic transplant.

BLOOD. 2001 NOV 16; 98 (11): 364B-364B

3793

3793 Chiorean EG, DeFor TE, Blazar BR, Weisdorf DJ, McGlave PB, et al.

Effect of donor chimerism on the GVHD risk and response to DLI for relapsed hematological malignancies after allogeneic transplantation.

BLOOD. 2001 NOV 16; 98 (11): 364B-364B

3794

3794 Kim YM, Mapara MY, Sykes M

Predominant role of CD8(+) T cells in the lymphohematopoietic graft-versus-host reaction mediated by donor lymphocyte infusion (DLI) in murine mixed chimeras.

BLOOD. 2001 NOV 16; 98 (11): 381A-381A

3795

3795 de Lima M, Komanduri K, StJohn L, Wieder E, Lee M, et al.

Using two mismatched unrelated donor cord blood units for transplantation: Analysis of chimerism and immune reconstitution.

BLOOD. 2001 NOV 16; 98 (11): 382B-382B

3796

3796 Hayashi S, Peranteau WH, Shaaban AF, Flake AW

Complete allogeneic hematopoietic chimerism without cytoreductive conditioning or immunosuppression: A combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.

BLOOD. 2001 NOV 16; 98 (11): 383A-383A

3797

3797 Hou JW, Fowler DH, Wilson W, Gress R, Kasten-Sportes C, et al.

Potent graft-versus-lymphoma effect after non-myeloablative stem cell transplant in refractory non-Hodgkin's lymphoma: Role of rapid complete donor chimerism.

BLOOD. 2001 NOV 16; 98 (11): 404A-404A

3798

3798 Scheffold C, Kroeger MJ, Silling G, Leo R, Zuehlsdorf M, et al.

Decreasing donor cell chimerism (DCC) in marrow CD34+ cells indicates relapse in acute myeloid leukemia (AML) after allogeneic stem cell transplantation.

BLOOD. 2001 NOV 16; 98 (11): 405A-405A

3799

3799 Dey BR, McAfee SL, Colby C, Sackstein R, Saidman S, et al.

Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-vs-host disease (GvHD) and anti-tumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic stem cell transplantation (SCT).

BLOOD. 2001 NOV 16; 98 (11): 417A-417A

3800

3800 Dey BR, McAfee SL, Sackstein R, Colby C, Sahai S, et al.

Achievement of sustained remissions despite loss of donor chimerism (DC) in patients with chemotherapy-refractory non-Hodgkin's lymphoma (NHL) treated with nonmyeloablative conditioning and allogeneic stem cell transplantation (SCT).

BLOOD. 2001 NOV 16; 98 (11): 418A-418A

Chimerism and Transplantation topic search 8998 papers downloaded from Web of Science. Topic=((chimer* OR microchimer) AND (graft OR allograft* OR homograft* OR transplant*)) Timespan=1950-01-01 - 2011-12-31. Databases=SCI-EXPANDED, SSCI, A&HCI. Lemmatization=Off AND 85 papers added from the cited references list.	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 52148, GCS 386809, CR 295585 Collection span: 1945 - 2011
List of All Records